18 results
8-K
EX-1.1
TERN
Terns Pharmaceuticals Inc
15 May 23
Entry into a Material Definitive Agreement
4:44pm
within the applicable rules and
regulations adopted by the Commission and the Public Company Accounting Oversight Board (United States
8-K
EX-1.1
TERN
Terns Pharmaceuticals Inc
23 Dec 22
Terns Announces Pricing of $75 Million Public Offering
4:10pm
subsidiaries within the applicable rules and regulations adopted by the Commission and the Public Company Accounting Oversight Board (United States
8-K
EX-1.1
l3ecd6 58
16 Aug 22
Terns Announces $65 Million Oversubscribed Offering
5:18pm
DEF 14A
0hiecg56 79g6a
29 Apr 22
Definitive proxy
4:22pm
S-3
EX-1.2
776kezpqwlqe
8 Mar 22
Shelf registration
4:34pm
10-K
iiiu4fcoimxm5z95m
30 Mar 21
Annual report
5:21pm
424B4
q23ipr
8 Feb 21
Prospectus supplement with pricing info
4:01pm
S-1/A
v6pw2ouvexm5xtsu9vju
1 Feb 21
IPO registration (amended)
7:05am
S-1/A
EX-1.1
4tdq4y0j0miib
1 Feb 21
IPO registration (amended)
7:05am
S-1
EX-10.16
8cw4ujt9e
15 Jan 21
IPO registration
5:22pm
S-1
rpomb34
15 Jan 21
IPO registration
5:22pm
DRS/A
wtuo7m fars6z
16 Dec 20
Draft registration statement (amended)
12:00am
DRS
xaqrw3
10 Nov 20
Draft registration statement
12:00am
- Prev
- 1
- Next